Gian Lifecare Ltd vs Vimta Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Gian Lifecare Ltd is ₹ 4.2 as of 23 Oct 15:30 . The P/E Ratio of Gian Lifecare Ltd changed from 9.8 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Vimta Labs Ltd changed from 16.6 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Gian Lifecare Ltd changed from ₹ 42.97 crore on March 2022 to ₹ 17.77 crore on March 2025 . This represents a CAGR of -19.81% over 4 yearsThe Market Cap of Vimta Labs Ltd changed from ₹ 355.7 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 years The revenue of Gian Lifecare Ltd for the Dec '25 is ₹ 1.21 crore as compare to the Sep '25 revenue of ₹ 0.75 crore. This represent the growth of 61.33% The revenue of Vimta Labs Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Gian Lifecare Ltd for the Dec '25 is ₹ 0.33 crore as compare to the Sep '25 ebitda of ₹ -0.32 crore. This represent the decline of -203% The ebitda of Vimta Labs Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Gian Lifecare Ltd changed from ₹ 0.09 crore to ₹ 0.1 crore over 7 quarters. This represents a CAGR of 6.21% The net profit of Vimta Labs Ltd changed from ₹ 12.28 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The Dividend Payout of Gian Lifecare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Vimta Labs Ltd changed from 20.79 % on March 2021 to 11.52 % on March 2026 . This represents a CAGR of -9.37% over 6 years .

About Gian Lifecare Ltd

Gian Life Care Limited was incorporated as a Public Limited Company and registered with the Registrar of Companies, Uttar Pradesh, Kanpur with the name & style 'Gian Life Care Limited' pursuant to a Certificate of Incorporation dated November 06, 2018.
Subsequently, Company acquired the entire business of M/s Gian Pathology & X-Ray, sole proprietorship concern of its Promoter Mr. Arun Kumar Gupta w.e.f.
March 01, 2019. Company is a fast growing professionally managed organization with an ultra-modem fully integrated, manufacturing facility dedicated to provide diagnostic services.
It established the organization in 2018.
Gian' is committed to Quality services that address the prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. The diagnostic center under the name of 'M/s.

About Vimta Labs Ltd

Vimta Labs Limited., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries.
Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas like preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products.

FAQs for the comparison of Gian Lifecare Ltd and Vimta Labs Ltd

Which company has a larger market capitalization, Gian Lifecare Ltd or Vimta Labs Ltd?

Market cap of Gian Lifecare Ltd is 4 Cr while Market cap of Vimta Labs Ltd is 2,096 Cr

What are the key factors driving the stock performance of Gian Lifecare Ltd and Vimta Labs Ltd?

The stock performance of Gian Lifecare Ltd and Vimta Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gian Lifecare Ltd and Vimta Labs Ltd?

As of October 25, 2026, the Gian Lifecare Ltd stock price is INR ₹4.2. On the other hand, Vimta Labs Ltd stock price is INR ₹468.95.

How do dividend payouts of Gian Lifecare Ltd and Vimta Labs Ltd compare?

To compare the dividend payouts of Gian Lifecare Ltd and Vimta Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.